|
|
Research Progress in Neuronal Differentiation of Induced Pluripotent Stem Cell |
SHAN Wei1, YU Qin1, LIU Li-zhen2, WANG Biao1 |
1. Institute of Biological Engineering, Zhejiang Chinese Medicine University, Hangzhou 310053, China; 2. Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China |
|
|
Abstract Induced pluripotent stem cell (iPSC), which is generated by reprogramming the somatic cells through thansfection of a combination of specific genes, owns the similar biological properties with embryonic stem cell. iPSC is morphologically identical to embryonic stem cell and show infinite proliferation, self-renewal abilities, teratoma formation after subcutaneous injection and contribution to chimeric animals on injection into blastocysts. Several molecular and functional assays are set to evaluate the similarity of iPSC with embryonic stem cell. Furthermore, the generation of iPSC overcomes the ethical difficulties and the risk of transplant rejection by the host immune system, implying great clinical potential. Great progresses have been achieved in the area of iPSC about treating the diseases of central nervous system, including the improvement of the methods about neuronal differentiation, the research of differentiation mechanisms and the treatment of neuronal cells derived from iPSC on the diseases of nervous system. The creation and characteristic of iPSC and the methods about neuronal differentiation of iPSC are reviewed. It also summarizes the recent progress in neuronal differentiation of iPSC.
|
Received: 12 January 2012
Published: 25 September 2012
|
|
|
|
[1] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4):663-676. [2] Yu J, Vodyanik M A, Smuga-Otto K, et al.Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318(5858):1917-1920. [3] Takahashi K, Tanabe K, Yamanaka S, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131(5):861-872. [4] Robinton D A, Daley G Q. The promise of induced pluripotent stem cells in research and therapy. Nature, 2012, 481(7381):295-305. [5] Li X J, Hu B Y, Zhang Y S, et al. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells, 2008, 26(4): 886-893. [6] Nemati S, Hatami M, Kiani S, et al. Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors. Stem Cell Dev, 2011, 20(3):503-514. [7] Elkabetz Y, Panagiotakos G, Al Shamy G, et al. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev, 2008, 22(2):152-165. [8] Elkabetz Y, Studer L. Human ESC-derived neural rosettes and neural stem cell progression. Cold Spring Harb Symp Quant Biol, 2008, 73:377-387. [9] Erceg S, Ronaghi M, Stojkovic M. Human embryonic stem cell differentiation toward regional specific neural precursors. Stem Cells, 2009, 27(1):78-87. [10] Parsons X H, Teng Y D, Parsons J F, et al. Efficient derivation of human neuronal progenitors and neurons from pluripotent human embryonic stem cells with small molecule induction. J VIS Exp, 2011, (56):3273. [11] Malgrange B, Borgs L, Grobarczyk B, et al. Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms. Cell Mol Life Sci, 2011, 68(4):635-649. [12] Cai C, Thorne J, Grabel L. Hedgehog serves as a mitogen and survival factor during embryonic stem cell. Stem Cell, 2008, 26(5):1097-1098. [13] Chaturvedi G, Simone PD, Ain R, et al. Noggin maintains pluripotency of human embryonic stem cells grown on Matrigel. Cell Prolif, 2009, 42(4):425-433. [14] Koch P, Opitz T, Steinbeck J A, et al. A rosette-type self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci USA, 2009, 106(9):3225-3230. [15] Preynat-Seauve O, Suter D M, Tirefort D, et al. Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells, 2009, 27(3):509-520. [16] Joannides A J, Fiore-Heriche C, Battersby A A, et al. A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells, 2007, 25(3):731-737. [17] Davidson K C, Jamshidi P, Daly R, et al. Wnt3a regulates survival, expansion, and maintenance of neural progenitors derived from human embryonic stem cells. Mol Cell Neurosci, 2007, 36(3):408-415. [18] Wada T, Honda M, Minami I, et al. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embry-onic stem cells. PLoS One, 2009, 4(8):e6722. [19] Kim D S, Lee J S, Leem J W, et al. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev, 2010, 6(2):270-281. [20] Chambers S M, Fasano C A, Papapetrou E P, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 2009, 27(3):275-280. [21] Hu B Y, Weick J P, Yu J Y, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA, 2010, 107(9):4335-4340. [22] Nemati S, Hatami M, Kiani S, et al. Long-Term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev, 2011, 20(3): 503-514. [23] Karumbayaram S, Novitch B G, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 2009, 27(4):806-811. [24] Kitazawa A, Shimizu N. Differentiation of mouse induced pluripotent stem cells into neurons using conditioned medium of dorsal root ganglia. New Biotechnology, 2011, 28(4):326-333. [25] Dimos J T, Rodolfa K T, Niakan K K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 2008, 321(5893):1218-1221. [26] Xu J, Wang H, Liang T, et al. In vitro induction of mouse meningeal-derived iPS cells into neural-like cells. Cell Biology, 2011, 56(15): 1556-1561. [27] Wernig M, Zhao J P, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Nat1 Acad Sci USA, 2008, 105(15):5856-5861. [28] Soldner F, Hockemeyer D, Beard C, et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136(5): 964-977. [29] Yahata N, Asai M, Kitaoka S, et al. Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer’s disease. PloS One, 2011, 6(9):e25788. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|